Literature DB >> 9792305

Transcriptional silencing of the p16 gene in human myeloma-derived cell lines by hypermethylation.

I H Wong1, M H Ng, J C Lee, K W Lo, Y F Chung, D P Huang.   

Abstract

Recently, p16 and p15 have been identified as commonly inactivated tumour suppressor genes in haematological malignancies. We previously reported that these genes were frequently hypermethylated in multiple myeloma (MM). To investigate how p16 and p15 inactivation are associated with hypermethylation, methylation status and transcription of these genes in six MM-derived cell lines were studied by Southern blot analysis and RT-PCR. Aberrant methylation of p16 was found in ARH-77, HS-Sultan, IM-9, RPMI-8226, U266-B1 and NCI-H929 MM cell lines. However, loss of p16 transcription was demonstrated only in HS-Sultan, RPMI-8226, U266-B1 and NCI-H929 with extensive methylation at the 5' upstream region of p16. Conversely, only HS-Sultan showed extensive methylation at the 5' upstream region of p15, which was associated with p15 transcriptional block. These results suggest that extensive methylation within a critical domain may be crucial in silencing p16 or p15 transcription. To demonstrate the reversibility of methylation and its relationship with transcription, HS-Sultan, RPMI-8226 and NCI-H929 were demethylated with 5-aza-2'-deoxycytidine. Restoration of gene transcription was observed and correlated with partial demethylation of the genes. The present data show that the p16 and p15 genes are silenced in MM by hypermethylation, which may play an important role in MM pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9792305

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

Review 1.  Epigenetic inactivation of tumor suppressor genes in hematologic malignancies.

Authors:  Tomohiro Kinoshita
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

2.  The novel histone deacetylase inhibitor, AR-42, inhibits gp130/Stat3 pathway and induces apoptosis and cell cycle arrest in multiple myeloma cells.

Authors:  Shuhong Zhang; Attaya Suvannasankha; Colin D Crean; Valerie L White; Ching-Shih Chen; Sherif S Farag
Journal:  Int J Cancer       Date:  2010-12-01       Impact factor: 7.396

Review 3.  New markers for cancer detection.

Authors:  Ivy H N Wong; Y M Dennis Lo
Journal:  Curr Oncol Rep       Date:  2002-11       Impact factor: 5.075

4.  Germinal center B-cells resist transformation by Kras independently of tumor suppressor Arf.

Authors:  Chelsea D Mullins; Mack Y Su; Vishwanathan Hucthagowder; Liang Chu; Lan Lu; Shashikant Kulkarni; Deborah Novack; Ravi Vij; Michael H Tomasson
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

5.  The epigenetic impact of suberohydroxamic acid and 5‑Aza‑2'‑deoxycytidine on DNMT3B expression in myeloma cell lines differing in IL‑6 expression.

Authors:  Katerina Smesny Trtkova; Petra Luzna; Denisa Weiser Drozdkova; Katerina Cizkova; Lucie Janovska; Jan Gursky; Dana Prukova; Ivo Frydrych; Marian Hajduch; Jiri Minarik
Journal:  Mol Med Rep       Date:  2022-08-31       Impact factor: 3.423

6.  Phenylhexyl isothiocyanate has dual function as histone deacetylase inhibitor and hypomethylating agent and can inhibit myeloma cell growth by targeting critical pathways.

Authors:  Quanyi Lu; Xianghua Lin; Jean Feng; Xiangmin Zhao; Ruth Gallagher; Marietta Y Lee; Jen-Wei Chiao; Delong Liu
Journal:  J Hematol Oncol       Date:  2008-06-09       Impact factor: 17.388

7.  Sensitive Melting Analysis after Real Time- Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection.

Authors:  Lasse S Kristensen; Thomas Mikeska; Michael Krypuy; Alexander Dobrovic
Journal:  Nucleic Acids Res       Date:  2008-03-15       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.